Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Reverse Transcriptase Inhibitors/administration & dosage/adverse"'
Autor:
Nathan Ford, Nicholas I. Paton, María Eugenia Socías, Evan Popoff, Keith Chan, Meg Doherty, Steve Kanters, Dieter Ayers, Matthew O. Wiens, Edward J Mills, Alexandra Calmy, Marco Vitoria, David A. Cooper, Sabin Nsanzimana
Publikováno v:
The Lancet HIV, Vol. 4, No 10 (2017) pp. e433-e441
Summary Background Selection of optimal second-line antiretroviral therapy (ART) has important clinical and programmatic implications. To inform the 2016 revision of the WHO ART guidelines, we assessed the comparative effectiveness and safety of avai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5606894d826bac37fb664fc6646ba841
https://doi.org/10.1016/s2352-3018(17)30109-1
https://doi.org/10.1016/s2352-3018(17)30109-1
Autor:
Somboon Tansuphasawadikul, David A. Cooper, Umaporn Siangphoe, Phitsanu Raksakulkarn, Kiat Ruxrungtham, Andrew F. Hill, Warangkana Munsakul, Sasisopin Kiertiburanakul, Ploenchan Chetchotisakd, Reto Nüesch, Wisit Prasithsirikul, Bernard Hirschel, Jintanat Ananworanich
Publikováno v:
Scopus-Elsevier
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
Antiviral Therapy, Vol. 10, No 6 (2005) pp. 761-767
ObjectiveTo assess the efficacy and safety of first-line treatment with once-daily saquinavir/ritonavir with two nucleoside reverse transcriptase inhibitors (NRTIs), as induction therapy before enrollment in a randomized trial of structured treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::becab3677e68c31cacbca2af440353cf
https://doi.org/10.1177/135965350501000604
https://doi.org/10.1177/135965350501000604
Autor:
Jim, Young, Juliane, Schäfer, Christoph A, Fux, Hansjakob, Furrer, Enos, Bernasconi, Pietro, Vernazza, Alexandra, Calmy, Matthias, Cavassini, Rainer, Weber, Manuel, Battegay, Heiner C, Bucher, S, Yerly
Publikováno v:
AIDS, Vol. 26, No 5 (2012) pp. 567-75
Background: Tenofovir is associated with reduced renal function, but it is not clear whether there is a greater decline in renal function when tenofovir is co-administered with a boosted protease inhibitor rather than with a nonnucleoside reverse tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89773cafd0a6a8e5115793d5ddc0d632
https://pubmed.ncbi.nlm.nih.gov/22398568
https://pubmed.ncbi.nlm.nih.gov/22398568
Autor:
Ford, Nathan, Calmy, Alexandra
Publikováno v:
Current Opinion in HIV and AIDS, Vol. 5, No 1 (2010) pp. 38-47
PURPOSE OF REVIEW: Access to first-line antiretroviral therapy in resource-limited settings has increased rapidly in the last 5 years. Newer medicines with greater potency and better safety profiles open the possibility for improving first-line antir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::4241cca5d85f5419f897e251184e9c9c
https://archive-ouverte.unige.ch/unige:20941
https://archive-ouverte.unige.ch/unige:20941
